CRT 2026

CARDIOGENIC SHOCK: PAST, PRESENT, AND FUTURE CLINICAL TRIALS

Moderator(s)

• 

  Jacob Eifer Møller, MD

  Consultant
  Rigshospitalet Copenhagen Denmark

  Disclosure(s): Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Magenta,: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Pooja Swamy, MD

  Interventional Cardiologist
  Loma Linda University Health , California, United States

  Disclosure information not submitted.
• 

  Alexander G. Truesdell, MD

  Interventional Cardiology
  Virginia Heart / Inova Schar Heart and Vascular
  McLean, Virginia, United States

  Disclosure(s): Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Getinge: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2024); Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)